Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow287.56 M USD298.98 M USD254.39 M USD325.27 M USD352.16 M USD205.22 M USD181.62 M USD170.37 M USD143.72 M USD144.16 M USD139.36 M USD136.76 M USD
Depreciation & Amortization109.90 M USD111.71 M USD107.24 M USD101.07 M USD87.75 M USD82.74 M USD78.17 M USD64.46 M USD60.04 M USD42.76 M USD37.23 M USD19.18 M USD
Stock-Based Compensation40.83 M USD38.04 M USD39.23 M USD42.18 M USD48.98 M USD32.37 M USD32.28 M USD28.24 M USD14.63 M USD9.43 M USD5.96 M USD3.52 M USD
Capital Expenditures31.01 M USD62.88 M USD38.24 M USD44.91 M USD44.30 M USD51.74 M USD25.41 M USD20.93 M USD15.18 M USD16.90 M USD19.91 M USD13.82 M USD
Cash Flow from Investing-35.18 M USD-203.03 M USD-265.65 M USD-96.85 M USD-243.52 M USD27.09 M USD-336.80 M USD-38.71 M USD-305.95 M USD-107.57 M USD-426.49 M USD49.69 M USD
Cash Flow from Financing-253.91 M USD-122.40 M USD22.62 M USD-242.85 M USD-62.55 M USD-183.80 M USD134.38 M USD-99.19 M USD189.11 M USD-23.37 M USD31.28 M USD-36.81 M USD
Dividends Paid50.39 M USD50.42 M USD50.28 M USD50.19 M USD49.62 M USD48.90 M USD48.36 M USD47.97 M USD47.33 M USD47.61 M USD47.11 M USD45.39 M USD
Stock Buybacks275.73 M USD80.04 M USD19.56 M USD160.95 M USD43.18 M USD50.11 M USD15.40 M USD0 USD0 USD0 USD
Free Cash Flow256.55 M USD236.10 M USD216.15 M USD280.36 M USD307.86 M USD153.47 M USD156.21 M USD149.43 M USD128.54 M USD127.26 M USD119.45 M USD122.94 M USD

Bio-Techne Corporation is a global life sciences company that develops, manufactures, and supplies specialized tools for research and clinical diagnostics. The company focuses on high-quality reagents, analytical instruments, and precision diagnostic products used across pharmaceutical, biotechnology, academic, and clinical laboratory settings. Through its protein sciences activities, Bio-Techne provides antibodies, bioactive proteins, assays, and related instruments that support investigations into cellular pathways, disease mechanisms, and therapeutic targets. Its diagnostics and spatial biology offerings include diagnostic reagents, molecular diagnostic solutions, and advanced platforms for visualizing and quantifying biomolecules in tissues, supporting pathology and translational research. Bio-Techne serves a diversified customer base involved in drug discovery, basic and applied research, and high-complexity diagnostic testing, helping ensure reproducible and consistent experimental results. Incorporated in 1981 and headquartered in Minneapolis, Minnesota, Bio-Techne today plays a significant role in the global life sciences infrastructure by providing critical consumables and instruments that are embedded in laboratory workflows worldwide.